After Eli Lilly, Novo Nordisk has teamed up with an Indian partner to market its weight-loss drug under a new brand name in the world’s third most obese country. Novo Nordisk will sell Poviztra 2.4 mg semaglutide injection in India as a separate brand of its blockbuster weight-loss drug WeGovy. (Reuters) The Danish drugmaker will […]
